News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,435 Results
Type
Article (87409)
Company Profile (759)
Press Release (772242)
Multimedia
Podcasts (171)
Webinars (28)
Section
Business (233046)
Career Advice (4139)
Deals (39793)
Drug Delivery (134)
Drug Development (91245)
Employer Resources (202)
FDA (18277)
Job Trends (17397)
News (397369)
Policy (39924)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (230)
Approvals (18291)
Artificial intelligence (484)
Autoimmune disease (69)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (158)
Biotechnology (484)
Bladder cancer (124)
Brain cancer (52)
Breast cancer (481)
Cancer (3836)
Cardiovascular disease (337)
Career advice (3556)
Career pathing (38)
CAR-T (244)
CDC (57)
Cell therapy (677)
Cervical cancer (32)
Clinical research (75334)
Collaboration (1369)
Company closure (4)
Compensation (930)
Complete response letters (59)
COVID-19 (2952)
CRISPR (81)
C-suite (578)
Cystic fibrosis (133)
Data (4303)
Decentralized trials (2)
Denatured (60)
Depression (109)
Diabetes (449)
Diagnostics (7087)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (229)
Drug pricing (188)
Drug shortages (36)
Duchenne muscular dystrophy (202)
Earnings (98757)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132868)
Executive appointments (984)
FDA (20699)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1242)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1015)
Government (5380)
Grass and pollen (7)
Guidances (337)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (239)
Immuno-oncology (20)
Indications (52)
Infectious disease (3185)
Inflammatory bowel disease (185)
Inflation Reduction Act (15)
Influenza (93)
Intellectual property (185)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (15)
Labor market (75)
Layoffs (639)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (546)
Lymphoma (261)
Machine learning (29)
Management (66)
Manufacturing (632)
MASH (137)
Medical device (14863)
Medtech (14886)
Mergers & acquisitions (22736)
Metabolic disorders (1144)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2705)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (57)
Obesity (555)
Opinion (311)
Ovarian cancer (127)
Pain (162)
Pancreatic cancer (168)
Parkinson's disease (239)
Partnered (30)
Patents (413)
Patient recruitment (303)
Peanut (57)
People (66234)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23232)
Phase II (32709)
Phase III (24607)
Pipeline (2672)
Policy (295)
Postmarket research (3554)
Preclinical (10486)
Press Release (72)
Prostate cancer (195)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (663)
Real estate (7421)
Recruiting (78)
Regulatory (27961)
Reports (64)
Research institute (2688)
Resumes & cover letters (651)
Rett syndrome (15)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (206)
Series B (154)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (95)
The Weekly (109)
Vaccines (1038)
Venture capital (66)
Weight loss (393)
Women's health (58)
Worklife (21)
Date
Today (149)
Last 7 days (544)
Last 30 days (2496)
Last 365 days (33566)
2025 (25971)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50929)
Australia (8952)
California (9351)
Canada (2834)
China (881)
Colorado (400)
Connecticut (419)
Delaware (261)
Europe (117032)
Florida (1374)
Georgia (313)
Hawaii (3)
Idaho (67)
Illinois (806)
India (50)
Indiana (455)
Iowa (19)
Japan (313)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1268)
Massachusetts (7044)
Michigan (310)
Minnesota (559)
Mississippi (4)
Missouri (118)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (77)
New Jersey (2587)
New Mexico (32)
New York (2548)
North Carolina (1405)
North Dakota (10)
Northern California (4212)
Ohio (294)
Oklahoma (22)
Oregon (50)
Pennsylvania (1952)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (48)
South Dakota (1)
Southern California (3574)
Tennessee (149)
Texas (1467)
United States (34616)
Utah (279)
Virginia (246)
Washington D.C. (83)
Washington State (808)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,435 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IN PARTNERSHIP WITH TRILINK BIOTECHNOLOGIES
Webinar: Design, Build, and Encapsulate: Transforming Digital Sequences into High-Quality, Ready-to-Test mRNA
This webinar, tailored for scientists in academia, biotech, and pharma, explores how intelligent mRNA designs can reduce experimental workloads and improve mRNA performance and efficacy.
October 15, 2025
·
1 min read
·
BioSpace Insights
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
Novo Nordisk struck another deal, this time with Omeros, amid a broader pipeline restructuring that recently claimed its cell therapy work.
October 15, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Marc Walther, President and CEO of Impact Fusion Files a Patent Pending Related to Artificial Insemination of Mammals
October 15, 2025
·
10 min read
Press Releases
Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025
October 15, 2025
·
1 min read
Press Releases
PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings
Expanding ketamine indications, fortifying IP, enabling earlier partnerships, and accelerating FDA pathways - underpinned by PharmaTher’s Digital Health AI division, leveraging the Company’s FDA-approved ketamine ANDA CMC and KetaVault(TM) data advantage.
October 15, 2025
·
7 min read
Press Releases
Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund
October 15, 2025
·
1 min read
Press Releases
Life Sciences IT Market to Capture USD 67.69 Billion by 2034, says Healthcare Experts
October 15, 2025
·
1 min read
Press Releases
Personalized Cancer Vaccine Market Size to Exceed USD 8,501.14 Million by 2034
October 15, 2025
·
1 min read
GLP-1
Lilly’s Oral GLP-1 Bests Another Big Pharma Bestseller in Phase III Diabetes Trial
After beating Novo Nordisk’s semaglutide last month, Lilly’s much anticipated oral candidate orforglipron has taken down AstraZeneca’s Farxiga in a head-to-head trial.
October 15, 2025
·
2 min read
·
Annalee Armstrong
Gene therapy
Sarepta’s Not Done With Gene Therapy Yet as LGMD Asset Yields Promising Data
Despite announcing a broad pivot to siRNA earlier this year, Sarepta is following through with an investigational gene therapy: its limb-girdle muscular dystrophy candidate. But the treatment’s path forward, analysts say, is highly uncertain.
October 15, 2025
·
6 min read
·
Tristan Manalac
1 of 86,044
Next
